From Multi‐Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR‐T Cell Therapy

Abstract Chimeric antigen receptor T (CAR‐T) cell therapies, a cornerstone of immunotherapy, have demonstrated remarkable efficacy in treating hematological malignancies and have more recently expanded into applications for solid tumors and autoimmune diseases. Emerging multidimensional profiling technologies offer promising solutions for enhancing CAR‐T efficacy, overcoming resistance, and facilitating the development of novel CAR‐T constructs. The integration of genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiomics enables a comprehensive understanding of the intrinsic mechanisms underlying CAR‐T therapy, while single‐cell and spatial omics significantly improve data resolution and analytical depth. Coupled with advances in biomedical engineering, visualization technologies form the foundation for omics data generation by bridging microscopic and macroscopic scales and enabling dynamic, 3D in vivo monitoring of CAR‐T behavior. Artificial intelligence (AI) further supports this framework by enabling the analysis of complex, high‐dimensional datasets. This review highlights recent advances in the integration of multidimensional omics within CAR‐T therapy and explores cutting‐edge developments in visualization technologies and AI applications. The full convergence of multi‐omics, visualization tools, and AI is poised to deliver transformative insights into the mechanisms governing CAR‐T cell therapy.